Loading...

Alan Venook, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1450 Third St
San Francisco CA 94158
Phone415-476-1421
ORCID ORCID Icon0000-0001-9749-6548 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco Residency School of Medicine
    University of California, San FranciscoM.D.1980 Medicine
    Collapse Awards and Honors
    National Cancer Institute2010Director's Service Award
    Healthnetwork Foundation2011Service Excellence Award
    National Comprehensive Cancer Network2013NCCN Board of Producers Award
    Colon Cancer Alliance2017Heroes of Hope Award
    Giants of Cancer Care2019Giant of Cancer Care in GI Oncology

    Collapse Overview 
    Collapse Overview
    Dr. Venook is a Medical Oncologist with expertise in Gastrointestinal cancers. He leads that program in the UCSF
    Helen Diller Family Comprehensive Cancer Center. The program boasts a robust clinical trials portfolio primarily for patients in need of new options.

    Collapse Research 
    Collapse Research Activities and Funding
    Cancer Center Support Grant
    NIH P30CA082103Aug 5, 1999 - Nov 30, 2015
    Role: Co-Investigator
    CANCER AND LEUKEMIA GROUP B
    NIH U10CA060138Jul 28, 1993 - Mar 31, 2003
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000079Dec 1, 1974 - Nov 30, 2003
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Clinical validation of a machine-learning derived signature predictive of outcomes from first-line oxaliplatin-based chemotherapy in advanced colorectal cancer. Clin Cancer Res. 2020 Dec 08. Abraham JP, Magee D, Cremolini C, Antoniotti C, Halbert DD, Xiu J, Stafford P, Berry DA, Oberley MJ, Shields AF, Marshall JL, Salem ME, Falcone A, Grothey A, Hall MJ, Venook AP, Lenz HJ, Helmstetter A, Korn WM, Spetzler DB. PMID: 33293373.
      View in: PubMed   Mentions:    Fields:    
    2. Genomic Analysis of Germline Variation Associated with Survival of Patients with Colorectal Cancer Treated with Chemotherapy Plus Biologics in CALGB/SWOG 80405 (Alliance). Clin Cancer Res. 2021 Jan 01; 27(1):267-275. Innocenti F, Sibley AB, Patil SA, Etheridge AS, Jiang C, Ou FS, Howell SD, Plummer SJ, Casey G, Bertagnolli MM, McLeod HL, Auman JT, Blanke CD, Furukawa Y, Venook AP, Kubo M, Lenz HJ, Parker JS, Ratain MJ, Owzar K. PMID: 32958699.
      View in: PubMed   Mentions:    Fields:    
    3. Association of Coffee Intake With Survival in Patients With Advanced or Metastatic Colorectal Cancer. JAMA Oncol. 2020 Sep 17. PMID: 32940631.
      View in: PubMed   Mentions:    Fields:    
    4. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2021 Feb; 5(1):pkaa074. Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, Pollak MN, Nixon AB, Mullen BC, O'Neil BH, Shaw JE, Polite BN, Benson AB, Atkins JN, Goldberg RM, Brown JC, O'Reilly EM, Mayer RJ, Blanke CD, Fuchs CS, Meyerhardt JA. PMID: 33426464.
      View in: PubMed   Mentions:
    5. Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer. Mol Ther. 2020 11 04; 28(11):2367-2378. PMID: 32730744.
      View in: PubMed   Mentions: 2     Fields:    
    6. ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nat Rev Clin Oncol. 2020 Dec; 17(12):757-770. Dasari A, Morris VK, Allegra CJ, Atreya C, Benson AB, Boland P, Chung K, Copur MS, Corcoran RB, Deming DA, Dwyer A, Diehn M, Eng C, George TJ, Gollub MJ, Goodwin RA, Hamilton SR, Hechtman JF, Hochster H, Hong TS, Innocenti F, Iqbal A, Jacobs SA, Kennecke HF, Lee JJ, Lieu CH, Lenz HJ, Lindwasser OW, Montagut C, Odisio B, Ou FS, Porter L, Raghav K, Schrag D, Scott AJ, Shi Q, Strickler JH, Venook A, Yaeger R, Yothers G, You YN, Zell JA, Kopetz S. PMID: 32632268.
      View in: PubMed   Mentions: 5     Fields:    
    7. NCCN Guidelines Insights: Rectal Cancer, Version 6.2020. J Natl Compr Canc Netw. 2020 Jul; 18(7):806-815. Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Garrido-Laguna I, Grem JL, Gunn A, Hoffe S, Hubbard J, Hunt S, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen K, Saltz L, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Johnson-Chilla A, Gurski LA. PMID: 32634771.
      View in: PubMed   Mentions:    Fields:    
    8. Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients. Oncologist. 2020 Sep; 25(9):772-779. Susko M, Wang CJ, Lazar AA, Kim S, Laffan A, Feng M, Ko A, Venook AP, Atreya CE, Van Loon K, Anwar M. PMID: 32390297.
      View in: PubMed   Mentions:    Fields:    
    9. A Multicenter Randomized Three-Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma. Oncologist. 2020 Nov; 25(11):925-e1603. El Dika I, Mayer RJ, Venook AP, Capanu M, LaQuaglia MP, Kobos R, O'Neill AF, Chou JF, Ly M, Ang C, O'Reilly EM, Gordan JD, Abou-Alfa GK. PMID: 32400000.
      View in: PubMed   Mentions:    Fields:    
    10. Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405. JNCI Cancer Spectr. 2020 Jun; 4(3):pkaa024. PMID: 33134818.
      View in: PubMed   Mentions:
    11. Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma. Oncologist. 2020 Dec; 25(12):e1837-e1845. Abou-Alfa GK, Mayer R, Venook AP, O'Neill AF, Beg MS, LaQuaglia M, Kingham PT, Kobos R, Basturk O, Brennan C, Yopp A, Harding JJ, Leong S, Crown J, Hoti E, Leonard G, Ly M, Bradley M, Valentino E, Markowitz D, Zukiwski A, Ren K, Gordan JD. PMID: 32154962.
      View in: PubMed   Mentions: 1     Fields:    
    12. Clinicopathologic Characteristics and Impact of Oophorectomy for Ovarian Metastases from Colorectal Cancer. Oncologist. 2020 07; 25(7):564-571. Ursem C, Zhou M, Paciorek A, Atreya CE, Ko AH, Venook A, Zhang L, Van Loon K. PMID: 32031306.
      View in: PubMed   Mentions:    Fields:    
    13. Feasibility and Acceptability of a Web-Based Dietary Intervention with Text Messages for Colorectal Cancer: A Randomized Pilot Trial. Cancer Epidemiol Biomarkers Prev. 2020 04; 29(4):752-760. Van Blarigan EL, Kenfield SA, Chan JM, Van Loon K, Paciorek A, Zhang L, Chan H, Savoie MB, Bocobo AG, Liu VN, Wong LX, Laffan A, Atreya CE, Miaskowski C, Fukuoka Y, Meyerhardt JA, Venook AP. PMID: 31941707.
      View in: PubMed   Mentions:    Fields:    
    14. Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence. Clin Colorectal Cancer. 2020 03; 19(1):1-4. Snyder RA, Fournier K, Royal R, Venook AP, Chang GJ. PMID: 31983613.
      View in: PubMed   Mentions:    Fields:    
    15. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation. J Gastrointest Cancer. 2019 Dec; 50(4):769-779. Savoie MB, Paciorek A, Zhang L, Van Blarigan EL, Sommovilla N, Abrams D, Atreya CE, Bergsland EK, Chern H, Kelley RK, Ko A, Laffan A, Sarin A, Varma MG, Venook AP, Van Loon K. PMID: 30058032.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance). JNCI Cancer Spectr. 2020 Feb; 4(1):pkz078. Brown JC, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Denlinger CS, Atkins JN, Goldberg RM, Ng K, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA. PMID: 32259016.
      View in: PubMed   Mentions:
    17. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin Cancer Res. 2019 12 15; 25(24):7497-7505. Yuan C, Sato K, Hollis BW, Zhang S, Niedzwiecki D, Ou FS, Chang IW, O'Neil BH, Innocenti F, Lenz HJ, Blanke CD, Goldberg RM, Venook AP, Mayer RJ, Fuchs CS, Meyerhardt JA, Ng K. PMID: 31548349.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    18. Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial. JAMA Oncol. 2019 Sep 05. Abou-Alfa GK, Shi Q, Knox JJ, Kaubisch A, Niedzwiecki D, Posey J, Tan BR, Kavan P, Goel R, Lammers PE, Bekaii-Saab TS, Tam VC, Rajdev L, Kelley RK, El Dika I, Zemla T, Potaracke RI, Balletti J, El-Khoueiry AB, Harding JH, Suga JM, Schwartz LH, Goldberg RM, Bertagnolli MM, Meyerhardt J, O'Reilly EM, Venook AP. PMID: 31486832.
      View in: PubMed   Mentions: 12     Fields:    
    19. Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 09 01; 17(9):1109-1133. Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Cohen SA, Cooper HS, Deming DA, Garrido-Laguna I, Grem JL, Hoffe SE, Hubbard J, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Nurkin S, Overman MJ, Parikh A, Patel H, Pedersen KS, Saltz LB, Schneider C, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Johnson-Chilla A, Gregory KM, Gurski LA. PMID: 31487687.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. Second-line chemotherapy in advanced biliary cancers: A retrospective, multicenter analysis of outcomes. Cancer. 2019 Dec 15; 125(24):4426-4434. Lowery MA, Goff LW, Keenan BP, Jordan E, Wang R, Bocobo AG, Chou JF, O'Reilly EM, Harding JJ, Kemeny N, Capanu M, Griffin AC, McGuire J, Venook AP, Abou-Alfa GK, Kelley RK. PMID: 31454426.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Targeted therapy for colorectal cancer metastases: A review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer. Cancer. 2019 Dec 01; 125(23):4139-4147. Piawah S, Venook AP. PMID: 31433498.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    22. Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. J Clin Oncol. 2019 10 10; 37(29):2620-2631. Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Sato K, Ng K, Van Blarigan E, Mayer RJ, Blanke CD, O'Reilly EM, Fuchs CS, Meyerhardt JA. PMID: 31408415.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Vitamin D Levels in Patients with Colorectal Cancer and Matched Household Members. J Clin Nutr Food Sci. 2019; 2. Savoie MB, Paciorek A, Zhang L, Sommovilla N, Venook AP, Van Blarigan EL, Van Loon K. PMID: 31423489.
      View in: PubMed   Mentions:
    24. High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma. PLoS One. 2019; 14(7):e0219469. Donner DB, Nakakura EK, Venook AP, Lenz HJ, Zhang W, Hwang J, Bergsland EK, Lin MH, Toriguchi K, Antonia RJ, Warren RS. PMID: 31291332.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Reply to S. Sorscher. J Clin Oncol. 2019 09 01; 37(25):2291-2293. Innocenti F, Ou FS, Qu X, Zemla T, Niedzwiecki D, Tam R, Mahajan S, Goldberg RM, Bertagnolli MM, Blanke CD, Sanoff H, Atkins J, Polite B, Venook AP, Lenz HJ, Kabbarah O. PMID: 31268798.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    26. RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer. JCI Insight. 2019 06 25; 5. Gbenedio OM, Bonnans C, Grun D, Wang CY, Hatch AJ, Mahoney MR, Barras D, Matli M, Miao Y, Garcia KC, Tejpar S, Delorenzi M, Venook AP, Nixon AB, Warren RS, Roose JP, Depeille P. PMID: 31237864.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    27. Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance). J Clin Oncol. 2019 08 01; 37(22):1876-1885. Lenz HJ, Ou FS, Venook AP, Hochster HS, Niedzwiecki D, Goldberg RM, Mayer RJ, Bertagnolli MM, Blanke CD, Zemla T, Qu X, Wirapati P, Tejpar S, Innocenti F, Kabbarah O. PMID: 31042420.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    28. Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. J Natl Compr Canc Netw. 2019 04 01; 17(4):302-310. Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD. PMID: 30959462.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    29. Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome. J Clin Oncol. 2019 05 10; 37(14):1217-1227. Innocenti F, Ou FS, Qu X, Zemla TJ, Niedzwiecki D, Tam R, Mahajan S, Goldberg RM, Bertagnolli MM, Blanke CD, Sanoff H, Atkins J, Polite B, Venook AP, Lenz HJ, Kabbarah O. PMID: 30865548.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    30. Self-monitoring and reminder text messages to increase physical activity in colorectal cancer survivors (Smart Pace): a pilot randomized controlled trial. BMC Cancer. 2019 Mar 11; 19(1):218. Van Blarigan EL, Chan H, Van Loon K, Kenfield SA, Chan JM, Mitchell E, Zhang L, Paciorek A, Joseph G, Laffan A, Atreya CE, Fukuoka Y, Miaskowski C, Meyerhardt JA, Venook AP. PMID: 30866859.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    31. Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance). J Natl Cancer Inst. 2019 02 01; 111(2):170-179. Morales-Oyarvide V, Yuan C, Babic A, Zhang S, Niedzwiecki D, Brand-Miller JC, Sampson-Kent L, Ye X, Li Y, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Wu K, Willett WC, Giovannucci EL, Wolpin BM, Meyerhardt JA, Fuchs CS, Ng K. PMID: 30726946.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    32. Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance). Clin Trials. 2019 04; 16(2):165-175. Schrag D, Weiser M, Saltz L, Mamon H, Gollub M, Basch E, Venook A, Shi Q. PMID: 30688523.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    33. Genetic variation determines VEGF-A plasma levels in cancer patients. Sci Rep. 2018 11 05; 8(1):16332. Innocenti F, Jiang C, Sibley AB, Etheridge AS, Hatch AJ, Denning S, Niedzwiecki D, Shterev ID, Lin J, Furukawa Y, Kubo M, Kindler HL, Auman JT, Venook AP, Hurwitz HI, McLeod HL, Ratain MJ, Gordan R, Nixon AB, Owzar K. PMID: 30397360.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Of Microbes and Microsatellites. Cancer Immunol Res. 2018 11; 6(11):1290-1291. Atreya CE, Venook AP. PMID: 30389718.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    35. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors. . 2018 12; 17(12):2702-2709. Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, Wang Y, Nakakura EK. PMID: 30254185.
      View in: PubMed   Mentions:
    36. The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation. PLoS One. 2018; 13(8):e0202272. Innocenti F, Owzar K, Jiang C, Etheridge AS, Gordân R, Sibley AB, Mulkey F, Niedzwiecki D, Glubb D, Neel N, Talamonti MS, Bentrem DJ, Seiser E, Yeh JJ, Van Loon K, McLeod H, Ratain MJ, Kindler HL, Venook AP, Nakamura Y, Kubo M, Petersen GM, Bamlet WR, McWilliams RR. PMID: 30107003.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsCTClinical Trials
    37. Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers. PLoS One. 2018; 13(7):e0199423. Atreya CE, Kubo A, Borno HT, Rosenthal B, Campanella M, Rettger JP, Joseph G, Allen IE, Venook AP, Altschuler A, Dhruva A. PMID: 30036361.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    38. Dietary Fat Intake after Colon Cancer Diagnosis in Relation to Cancer Recurrence and Survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev. 2018 10; 27(10):1227-1230. Van Blarigan EL, Ou FS, Niedzwiecki D, Zhang S, Fuchs CS, Saltz L, Mayer RJ, Venook A, Ogino S, Song M, Benson A, Hantel A, Atkins JN, Giovannucci EL, Meyerhardt JA. PMID: 30038051.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    39. Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance). PLoS One. 2018; 13(7):e0199244. Guercio BJ, Zhang S, Niedzwiecki D, Li Y, Babic A, Morales-Oyarvide V, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Zoltick ES, Stampfer M, Ng K, Wu K, Willett WC, Giovannucci EL, Meyerhardt JA, Fuchs CS. PMID: 30024889.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    40. Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma. N Engl J Med. 2018 Jul 05; 379(1):54-63. Abou-Alfa GK, Meyer T, Cheng AL, El-Khoueiry AB, Rimassa L, Ryoo BY, Cicin I, Merle P, Chen Y, Park JW, Blanc JF, Bolondi L, Klümpen HJ, Chan SL, Zagonel V, Pressiani T, Ryu MH, Venook AP, Hessel C, Borgman-Hagey AE, Schwab G, Kelley RK. PMID: 29972759.
      View in: PubMed   Mentions: 245     Fields:    Translation:HumansCTClinical Trials
    41. Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 07; 16(7):852-871. Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA. PMID: 30006428.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    42. Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 07; 16(7):874-901. Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Gurski L, Freedman-Cass DA. PMID: 30006429.
      View in: PubMed   Mentions: 78     Fields:    Translation:Humans
    43. Identification of a Genomic Region between SLC29A1 and HSP90AB1 Associated with Risk of Bevacizumab-Induced Hypertension: CALGB 80405 (Alliance). Clin Cancer Res. 2018 10 01; 24(19):4734-4744. Li M, Mulkey F, Jiang C, O'Neil BH, Schneider BP, Shen F, Friedman PN, Momozawa Y, Kubo M, Niedzwiecki D, Hochster HS, Lenz HJ, Atkins JN, Rugo HS, Halabi S, Kelly WK, McLeod HL, Innocenti F, Ratain MJ, Venook AP, Owzar K, Kroetz DL. PMID: 29871907.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    44. Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial. JAMA Oncol. 2018 06 01; 4(6):783-790. Van Blarigan EL, Fuchs CS, Niedzwiecki D, Zhang S, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Ng K, Meyerhardt JA. PMID: 29710284.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    45. Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). JNCI Cancer Spectr. 2018 Feb; 2(2):pky017. PMID: 29877501.
      View in: PubMed   Mentions:
    46. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. JAMA. 2018 05 22; 319(20):2104-2115. Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ. PMID: 29800181.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    47. Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer. J Natl Compr Canc Netw. 2018 05; 16(5S):611-615. Grothey A, Venook AP. PMID: 29784738.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    48. Advances in Adjuvant Therapy for Colon Cancer: P value or Practical Value. J Clin Oncol. 2018 05 20; 36(15):1461-1462. Venook AP. PMID: 29620996.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. NCCN Guidelines Insights: Colon Cancer, Version 2.2018. J Natl Compr Canc Netw. 2018 Apr; 16(4):359-369. Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Garrido-Laguna I, Grem JL, Grothey A, Hochster HS, Hoffe S, Hunt S, Kamel A, Kirilcuk N, Krishnamurthi S, Messersmith WA, Meyerhardt J, Miller ED, Mulcahy MF, Murphy JD, Nurkin S, Saltz L, Sharma S, Shibata D, Skibber JM, Sofocleous CT, Stoffel EM, Stotsky-Himelfarb E, Willett CG, Wuthrick E, Gregory KM, Freedman-Cass DA. PMID: 29632055.
      View in: PubMed   Mentions: 96     Fields:    Translation:Humans
    50. Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance). J Clin Oncol. 2018 04 10; 36(11):1112-1120. Fadelu T, Zhang S, Niedzwiecki D, Ye X, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson AB, Atienza DM, Messino M, Kindler HL, Venook A, Ogino S, Ng K, Wu K, Willett W, Giovannucci E, Meyerhardt J, Bao Y, Fuchs CS. PMID: 29489429.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    51. Marine ?-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance). Cancer Epidemiol Biomarkers Prev. 2018 04; 27(4):438-445. Van Blarigan EL, Fuchs CS, Niedzwiecki D, Ye X, Zhang S, Song M, Saltz LB, Mayer RJ, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Ogino S, Giovannucci EL, Meyerhardt JA. PMID: 29358223.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    52. The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer. Oncology (Williston Park). 2017 11 15; 31(11):785-8, 802. Ursem C, Venook AP. PMID: 29179247.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    53. Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). J Clin Oncol. 2017 Nov 10; 35(32):3671-3677. Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Ye X, Swanson RS, Enzinger PC, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, Ciombor K, Berg DJ, Meyerhardt J, Mayer RJ. PMID: 28976791.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    54. Challenges of conducting a prospective clinical trial for older patients: Lessons learned from NCCTG N0949 (alliance). J Geriatr Oncol. 2018 01; 9(1):24-31. McCleary NJ, Hubbard J, Mahoney MR, Meyerhardt JA, Sargent D, Venook A, Grothey A. PMID: 28917648.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann Oncol. 2017 Aug 01; 28(8):1713-1729. PMID: 28407110.
      View in: PubMed   Mentions: 131     Fields:    Translation:Humans
    56. Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials. JAMA Oncol. 2017 Aug 01; 3(8):1043-1050. PMID: 28208174.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    57. Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial. JAMA. 2017 06 20; 317(23):2392-2401. PMID: 28632865.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    58. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance). Ann Oncol. 2017 Jun 01; 28(6):1359-1367. PMID: 28327908.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    59. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw. 2017 05; 15(5):563-573. Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Zhu AX, Hoffmann KG, Darlow S. PMID: 28476736.
      View in: PubMed   Mentions: 75     Fields:    Translation:Humans
    60. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 03; 15(3):370-398. PMID: 28275037.
      View in: PubMed   Mentions: 154     Fields:    Translation:Humans
    61. Differences in symptom occurrence, severity, and distress ratings between patients with gastrointestinal cancers who received chemotherapy alone or chemotherapy with targeted therapy. J Gastrointest Oncol. 2017 Feb; 8(1):109-126. PMID: 28280616.
      View in: PubMed   Mentions:
    62. Reply to L. Casadaban et al. J Clin Oncol. 2017 04 20; 35(12):1373-1374. PMID: 28113023.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    63. Right-sided vs left-sided colorectal cancer. Clin Adv Hematol Oncol. 2017 Jan; 15(1):22-24. PMID: 28212365.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    64. Prolonged Response to HER2-Directed Therapy in a Patient With HER2-Amplified, Rapidly Progressive Metastatic Colorectal Cancer. J Natl Compr Canc Netw. 2017 01; 15(1):3-8. PMID: 28040715.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    65. Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference. J Gastrointest Oncol. 2016 Dec; 7(6):819-827. PMID: 28078106.
      View in: PubMed   Mentions:
    66. Role of Biologics in Colon Cancer: Still Not Clear. J Oncol Pract. 2016 12; 12(12):1229-1230. PMID: 27943687.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    67. Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location. J Natl Compr Canc Netw. 2016 12; 14(12):1536-1543. PMID: 27956538.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    68. Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study. J Gastrointest Oncol. 2016 Dec; 7(6):860-874. PMID: 28078110.
      View in: PubMed   Mentions:
    69. Oxaliplatin-Fluoropyrimidine Chemotherapy Plus Bevacizumab in Advanced Neuroendocrine Tumors: An Analysis of 2 Phase II Trials. Pancreas. 2016 11; 45(10):1394-1400. PMID: 27171514.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    70. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg. 2016 08 17; 151(8):e161137. PMID: 27275632.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    71. Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Cancer Med. 2016 09; 5(9):2249-60. PMID: 27465221.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    72. Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study. J Hepatol. 2016 12; 65(6):1140-1147. PMID: 27469901.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    73. Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance). J Clin Oncol. 2016 09 01; 34(25):3047-53. PMID: 27432924.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    74. CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. J Clin Oncol. 2016 08 10; 34(23):2736-42. PMID: 27382098.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCTClinical Trials
    75. Metastatic Colorectal Cancer: Lessons Learned, Future Possibilities. J Natl Compr Canc Netw. 2016 05; 14(5 Suppl):666-8. PMID: 27226509.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    76. Adjuvant Therapy Trials. Cancer J. 2016 May-Jun; 22(3):196-8. PMID: 27341598.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    77. A phase II study of axitinib in advanced neuroendocrine tumors. Endocr Relat Cancer. 2016 05; 23(5):411-8. PMID: 27080472.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    78. Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study. Liver Int. 2016 08; 36(8):1196-205. PMID: 26901163.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    79. Gene Expression Profiling of Evening Fatigue in Women Undergoing Chemotherapy for Breast Cancer. Biol Res Nurs. 2016 07; 18(4):370-85. PMID: 26957308.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    80. A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. Pancreas. 2016 Mar; 45(3):370-5. PMID: 26390428.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCellsCTClinical Trials
    81. TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON. Radiology. 2016 May; 279(2):630-40. PMID: 26744927.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    82. NCCN Oncology Research Program's Investigator Steering Committee and NCCN Best Practices Committee Molecular Profiling Surveys. J Natl Compr Canc Netw. 2015 Nov; 13(11):1337-46. PMID: 26553764.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    83. Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in BRAF V600-Mutant Colorectal Cancer. J Clin Oncol. 2015 Dec 01; 33(34):4023-31. PMID: 26392102.
      View in: PubMed   Mentions: 132     Fields:    Translation:HumansAnimalsCTClinical Trials
    84. Subgroups of chemotherapy patients with distinct morning and evening fatigue trajectories. Support Care Cancer. 2016 Apr; 24(4):1473-85. PMID: 26361758.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    85. The value and effectiveness of angiogenesis inhibitors for colorectal cancer. Clin Adv Hematol Oncol. 2015 Sep; 13(9):561-3. PMID: 26452184.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    86. Trying to Understand Differing Results of FIRE-3 and 80405: Does the First Treatment Matter More Than Others? J Clin Oncol. 2015 Nov 10; 33(32):3686-8. PMID: 26324365.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    87. Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). J Clin Oncol. 2015 Nov 01; 33(31):3598-607. PMID: 26282659.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    88. A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma. Clin Cancer Res. 2016 Jan 01; 22(1):61-8. PMID: 26251290.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsCTClinical Trials
    89. On the Verge: Immunotherapy for Colorectal Carcinoma. J Natl Compr Canc Netw. 2015 Aug; 13(8):970-8. PMID: 26285242.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    90. Rectal Cancer, Version 2.2015. J Natl Compr Canc Netw. 2015 Jun; 13(6):719-28; quiz 728. PMID: 26085388.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    91. Special Series: Advances in GI Cancer. J Clin Oncol. 2015 Jun 01; 33(16):1717-20. PMID: 25918284.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    92. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls. BMC Cancer. 2015 Mar 31; 15:206. PMID: 25884197.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsCTClinical Trials
    93. Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma. Liver Cancer. 2015 Mar; 4(2):115-25. PMID: 26020033.
      View in: PubMed   Mentions:
    94. Bevacizumab vs EGFR antibodies in metastatic colorectal cancer. Clin Adv Hematol Oncol. 2015 Feb; 13(2):90-2. PMID: 25774477.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    95. Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors. J Clin Oncol. 2015 Mar 20; 33(9):1060-6. PMID: 25605849.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCellsCTClinical Trials
    96. Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol. 2015 Mar 01; 33(7):786-809. PMID: 25605863.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    97. Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Clin Cancer Res. 2015 Mar 01; 21(5):1078-86. PMID: 25520391.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    98. A case series of patients with HER2-overexpressed primary metastatic gastroesophageal adenocarcinoma. Anticancer Res. 2014 Dec; 34(12):7357-60. PMID: 25503172.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    99. Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802). J Natl Cancer Inst. 2015 Jan; 107(1):336. PMID: 25432408.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    100. Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. J Natl Cancer Inst. 2015 Jan; 107(1):345. PMID: 25432409.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    101. Bone metastases and skeletal-related events from neuroendocrine tumors. Endocr Connect. 2015 Mar; 4(1):9-17. PMID: 25430999.
      View in: PubMed   Mentions:
    102. Progression-free survival: helpful biomarker or clinically meaningless end point? J Clin Oncol. 2015 Jan 01; 33(1):4-6. PMID: 25366687.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    103. NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies. J Natl Compr Canc Netw. 2014 Nov; 12(11):1629-49. PMID: 25361808.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    104. Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. Int J Cancer. 2015 Apr 15; 136(8):1967-75. PMID: 25242168.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    105. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst. 2014 Aug; 106(8). PMID: 25099612.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    106. Hepatobiliary cancers, version 2.2014. J Natl Compr Canc Netw. 2014 Aug; 12(8):1152-82. PMID: 25099447.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    107. Colon cancer, version 3.2014. J Natl Compr Canc Netw. 2014 Jul; 12(7):1028-59. PMID: 24994923.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    108. Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance). PLoS One. 2014; 9(6):e99816. PMID: 24937507.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    109. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study. J Gastrointest Cancer. 2014 Jun; 45(2):168-80. PMID: 24448917.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    110. CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer. Gastroenterology. 2014 Sep; 147(3):637-45. PMID: 24859205.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCellsCTClinical Trials
    111. International adaptations of NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2014 May; 12(5):643-8. PMID: 24812133.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    112. Progress against GI cancer during the American Society of Clinical Oncology's first 50 years. J Clin Oncol. 2014 May 20; 32(15):1521-30. PMID: 24752046.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    113. American Society of Clinical Oncology perspective: Raising the bar for clinical trials by defining clinically meaningful outcomes. J Clin Oncol. 2014 Apr 20; 32(12):1277-80. PMID: 24638016.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    114. Curable patient with metastatic colorectal cancer: balancing effective therapies and toxicities. J Clin Oncol. 2014 Apr 01; 32(10):991-6. PMID: 24516031.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    115. Colorectal cancer: all hands on deck. Am Soc Clin Oncol Educ Book. 2014; 83-9. PMID: 24857064.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimals
    116. A review of hepatocellular carcinoma (HCC) staging systems. Chin Clin Oncol. 2013 Dec; 2(4):33. PMID: 25841912.
      View in: PubMed   Mentions: 22     Fields:    
    117. Prognostic and predictive blood-based biomarkers in patients with advanced pancreatic cancer: results from CALGB80303 (Alliance). Clin Cancer Res. 2013 Dec 15; 19(24):6957-66. PMID: 24097873.
      View in: PubMed   Mentions: 44     Fields:    Translation:Humans
    118. Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance. Clin Colorectal Cancer. 2013 Dec; 12(4):233-8. PMID: 24035029.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    119. A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer. Br J Cancer. 2013 Oct 01; 109(7):1725-34. Kelley RK, Hwang J, Magbanua MJ, Watt L, Beumer JH, Christner SM, Baruchel S, Wu B, Fong L, Yeh BM, Moore AP, Ko AH, Korn WM, Rajpal S, Park JW, Tempero MA, Venook AP, Bergsland EK. PMID: 24022191.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    120. Biomarkers in colon cancer: the chasm between expectations and reality. Oncology (Williston Park). 2013 Aug; 27(8):758, 763. PMID: 24133822.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    121. The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached? Lancet Oncol. 2013 Jun; 14(7):e283-8. PMID: 23725711.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    122. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013 May 01; 11(5):519-28. PMID: 23667203.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    123. Predictive biomarkers for bevacizumab: are we there yet? Clin Cancer Res. 2013 Jun 01; 19(11):2824-7. PMID: 23549876.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    124. Biologic determinants of tumor recurrence in stage II colon cancer: validation study of the 12-gene recurrence score in cancer and leukemia group B (CALGB) 9581. J Clin Oncol. 2013 May 10; 31(14):1775-81. PMID: 23530100.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    125. Temsirolimus combined with sorafenib in hepatocellular carcinoma: a phase I dose-finding trial with pharmacokinetic and biomarker correlates. Ann Oncol. 2013 Jul; 24(7):1900-1907. PMID: 23519998.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCellsCTClinical Trials
    126. Borderline resectable pancreatic cancer: need for standardization and methods for optimal clinical trial design. Ann Surg Oncol. 2013 Aug; 20(8):2787-95. PMID: 23435609.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    127. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013 Feb 01; 11(2):141-52; quiz 152. PMID: 23411381.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    128. Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405. Clin Colorectal Cancer. 2013 Jun; 12(2):95-102. PMID: 23317558.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    129. Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade? Am Soc Clin Oncol Educ Book. 2013. PMID: 23714476.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    130. Novel therapeutics in hepatocellular carcinoma: how can we make progress? Am Soc Clin Oncol Educ Book. 2013. PMID: 23714481.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    131. Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium. Gastrointest Cancer Res. 2013 Jan; 6(1):3-9. PMID: 23505572.
      View in: PubMed   Mentions:
    132. Rectal cancer. J Natl Compr Canc Netw. 2012 Dec 01; 10(12):1528-64. PMID: 23221790.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    133. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012 Nov 21; 104(22):1702-11. PMID: 23136358.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansPHPublic Health
    134. Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gain. J Natl Compr Canc Netw. 2012 Nov 01; 10(11):1379-86. PMID: 23138166.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    135. Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas. Am J Clin Oncol. 2012 Oct; 35(5):411-7. Ko AH, Espinoza AM, Jones KA, Venook AP, Bergsland EK, Kelley RK, Dito E, Ong A, Hanover CS, Coakley FV, Tempero MA. PMID: 21552099.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    136. When progressive disease does not mean treatment failure: reconsidering the criteria for progression. J Natl Cancer Inst. 2012 Oct 17; 104(20):1534-41. PMID: 22927506.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    137. Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients. Pancreas. 2012 Aug; 41(6):840-4. PMID: 22781907.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    138. Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial. Liver Transpl. 2012 May; 18(5):509-13. PMID: 22389236.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    139. Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2012 Apr; 10(4):449-54. PMID: 22491045.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    140. Predictive biomarkers in advance of a companion drug: ahead of their time? J Natl Compr Canc Netw. 2012 Mar; 10(3):303-9. PMID: 22393192.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    141. Metastatic colorectal cancer: a curable disease. Oncology (Williston Park). 2012 Mar; 26(3):275-6, 282. PMID: 22545312.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    142. Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol. 2012 Feb; 23(2):153-63. PMID: 22264550.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    143. Is there currently an established role for the use of predictive or prognostic molecular markers in the management of colorectal cancer? A point/counterpoint. Am Soc Clin Oncol Educ Book. 2012; 193-200. PMID: 24451733.
      View in: PubMed   Mentions:    Fields:    
    144. Biomarker use in colorectal cancer therapy. J Natl Compr Canc Netw. 2011 Nov; 9(11):1293-302. PMID: 22056657.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    145. Colon cancer. J Natl Compr Canc Netw. 2011 Nov; 9(11):1238-90. PMID: 22056656.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    146. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. J Natl Cancer Inst. 2011 Oct 19; 103(20):1540-51. PMID: 21849660.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    147. Adjuvant treatment of colon cancer: what is next? Curr Opin Oncol. 2011 Jul; 23(4):403-9. Van Loon K, Venook AP. PMID: 21537178.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    148. Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303). Cancer. 2012 Jan 15; 118(2):571-8. Roberts AS, Campa MJ, Gottlin EB, Jiang C, Owzar K, Kindler HL, Venook AP, Goldberg RM, O'Reilly EM, Patz EF. PMID: 21713765.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    149. Lactic acidosis and colon cancer: oncologic emergency? Clin Colorectal Cancer. 2011 Sep; 10(3):194-7. PMID: 21855042.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    150. Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling? Clin Colorectal Cancer. 2011 Jun; 10(2):73-80. Kelley RK, Venook AP. PMID: 21859557.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    151. Long-term outcome of early-stage rectal cancer undergoing standard resection and local excision. Clin Colorectal Cancer. 2011 Mar 01; 10(1):37-41. PMID: 21609934.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    152. "And what other medications are you taking?". J Clin Oncol. 2011 Apr 10; 29(11):e288-91. PMID: 21245436.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    153. Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw. 2011 Jan; 9(1):13-25. Kelley RK, Van Bebber SL, Phillips KA, Venook AP. PMID: 21233242.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    154. Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect. Cancer. 2011 Apr 01; 117(7):1415-21. Peng J, Sheng W, Huang D, Venook AP, Xu Y, Guan Z, Cai S. PMID: 21425141.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    155. Nonadherence to imatinib during an economic downturn. N Engl J Med. 2010 Aug 05; 363(6):596-8. Kelley RK, Venook AP. PMID: 20818898.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    156. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol. 2010 Sep 01; 28(25):3994-4005. Thomas MB, Jaffe D, Choti MM, Belghiti J, Curley S, Fong Y, Gores G, Kerlan R, Merle P, O'Neil B, Poon R, Schwartz L, Tepper J, Yao F, Haller D, Mooney M, Venook A. PMID: 20679622.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    157. Hepatocellular carcinoma: Ablate and wait versus rapid transplantation. Liver Transpl. 2010 Aug; 16(8):925-9. Roberts JP, Venook A, Kerlan R, Yao F. PMID: 20658555.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    158. Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study. Int J Clin Pract. 2010 Jul; 64(8):1034-41. Lencioni R, Marrero J, Venook A, Ye SL, Kudo M. PMID: 20642705.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    159. Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement. HPB (Oxford). 2010 Jun; 12(5):313-20. Schwarz RE, Abou-Alfa GK, Geschwind JF, Krishnan S, Salem R, Venook AP. PMID: 20590905.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    160. Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer. J Clin Oncol. 2010 Jul 20; 28(21):3485-90. Chung KY, Gore I, Fong L, Venook A, Beck SB, Dorazio P, Criscitiello PJ, Healey DI, Huang B, Gomez-Navarro J, Saltz LB. PMID: 20498386.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCTClinical Trials
    161. Identification of unknown primary tumors in patients with neuroendocrine liver metastases. Arch Surg. 2010 Mar; 145(3):276-80. Wang SC, Parekh JR, Zuraek MB, Venook AP, Bergsland EK, Warren RS, Nakakura EK. PMID: 20231629.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    162. A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer. Cancer Chemother Pharmacol. 2010 Nov; 66(6):1051-7. Ko AH, Venook AP, Bergsland EK, Kelley RK, Korn WM, Dito E, Schillinger B, Scott J, Hwang J, Tempero MA. PMID: 20130876.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCTClinical Trials
    163. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist. 2010; 15 Suppl 4:5-13. Venook AP, Papandreou C, Furuse J, de Guevara LL. PMID: 21115576.
      View in: PubMed   Mentions: 313     Fields:    Translation:Humans
    164. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Oncologist. 2010; 15 Suppl 4:42-52. PMID: 21115580.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    165. NCCN clinical practice guidelines in oncology. Anal carcinoma. J Natl Compr Canc Netw. 2010 Jan; 8(1):106-20. Engstrom PF, Arnoletti JP, Benson AB, Berlin JD, Berry JM, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Knol JA, Leong LA, Lin E, Mulcahy MF, Rohren E, Ryan DP, Saltz L, Shibata D, Skibber JM, Small W, Sofocleous C, Thomas J, Venook AP, Willett C. PMID: 20064293.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    166. NCCN Clinical Practice Guidelines in Oncology: colon cancer. J Natl Compr Canc Netw. 2009 Sep; 7(8):778-831. Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. PMID: 19755046.
      View in: PubMed   Mentions: 165     Fields:    Translation:Humans
    167. NCCN Clinical Practice Guidelines in Oncology: rectal cancer. J Natl Compr Canc Netw. 2009 Sep; 7(8):838-81. Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C. PMID: 19755047.
      View in: PubMed   Mentions: 129     Fields:    Translation:Humans
    168. Drug development in advanced colorectal cancer: challenges and opportunities. Curr Oncol Rep. 2009 May; 11(3):175-85. Kelley R, Venook AP. PMID: 19336009.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    169. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009 Apr; 7(4):350-91. Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park JO, Posey JA, Sachdev J, Salem R, Sigurdson ER, Sofocleous C, Vauthey JN, Venook AP, Goff LW, Yen Y, Zhu AX. PMID: 19406039.
      View in: PubMed   Mentions: 192     Fields:    Translation:Humans
    170. A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher. Gastrointest Cancer Res. 2009 Mar; 3(2):45-8. Shah U, O'Neil B, Allen J, Goldberg RM, Bernard S, Moore D, Venook AP, Morse MM. PMID: 19461906.
      View in: PubMed   Mentions:
    171. Design issues in dose-finding Phase I trials for combinations of two agents. J Biopharm Stat. 2009; 19(3):509-23. Fan SK, Venook AP, Lu Y. PMID: 19384692.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    172. Sorafenib in hepatocellular carcinoma: separating the hype from the hope. J Clin Oncol. 2008 Dec 20; 26(36):5845-8. Kelley RK, Venook AP. PMID: 19029408.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    173. Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy. Pancreas. 2008 Oct; 37(3):269-74. Wong D, Ko AH, Hwang J, Venook AP, Bergsland EK, Tempero MA. PMID: 18815548.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    174. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2009 Jan; 7(1):104-13. Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, Kanke F, Schwartz ME, Sherman M. PMID: 18849011.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    175. NCCN Task Force Report: mTOR inhibition in solid tumors. J Natl Compr Canc Netw. 2008 Sep; 6 Suppl 5:S1-20; quiz S21-2. Figlin RA, Brown E, Armstrong AJ, Akerley W, Benson AB, Burstein HJ, Ettinger DS, Febbo PG, Fury MG, Hudes GR, Kies MS, Kwak EL, Morgan RJ, Mortimer J, Reckamp K, Venook AP, Worden F, Yen Y. PMID: 18926092.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    176. The impact of new data in the treatment of advanced hepatocellular carcinoma. Curr Oncol Rep. 2008 May; 10(3):199-205. Abou-Alfa GK, Venook AP. PMID: 18765149.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    177. A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable? Invest New Drugs. 2008 Oct; 26(5):463-71. Ko AH, Dito E, Schillinger B, Venook AP, Xu Z, Bergsland EK, Wong D, Scott J, Hwang J, Tempero MA. PMID: 18379729.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    178. Responding to the rising incidence of hepatocellular carcinoma with targeted therapy. Gastrointest Cancer Res. 2008 Mar; 2(2):96-7. Choo SP, Venook AP. PMID: 19259302.
      View in: PubMed   Mentions:
    179. Excess toxicity associated with docetaxel and irinotecan in patients with metastatic, gemcitabine-refractory pancreatic cancer: results of a phase II study. Cancer Invest. 2008 Feb; 26(1):47-52. Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA. PMID: 18181045.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    180. Phase II trial of T138067, a novel microtubule inhibitor, in patients with metastatic, refractory colorectal carcinoma. Clin Colorectal Cancer. 2008 Jan; 7(1):44-7. Berlin JD, Venook A, Bergsland E, Rothenberg M, Lockhart AC, Rosen L. PMID: 18279576.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    181. Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy. Oncologist. 2007 Dec; 12(12):1425-32. O'Neil BH, Venook AP. PMID: 18165619.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    182. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64. Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ. PMID: 18008108.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    183. Section I: essentials of ensuring excellence in cancer care. Gastrointest Cancer Res. 2007 Nov; 1(6 Suppl):S1-3. Goldberg RM, Marshall JL, Kachnic LA, Venook AP. PMID: 19330057.
      View in: PubMed   Mentions:
    184. Section III: Treatment of Advanced Gastrointestinal Cancers. Gastrointest Cancer Res. 2007 Nov; 1(6 Suppl):S8-S12. Hochster HS, O'Reilly EM, Ajani JA, Venook AP. PMID: 19330060.
      View in: PubMed   Mentions:
    185. Section IV: Significance of Recent Study Results and Future Research Directions in Gastrointestinal Oncology. Gastrointest Cancer Res. 2007 Nov; 1(6 Suppl):S13-6. Goldberg RM, Marshall JL, Ajani JA, Philip PA, O'Reilly EM, Venook AP. PMID: 19330058.
      View in: PubMed   Mentions:
    186. Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides. J Immunother. 2007 Oct; 30(7):762-72. Kavanagh B, Ko A, Venook A, Margolin K, Zeh H, Lotze M, Schillinger B, Liu W, Lu Y, Mitsky P, Schilling M, Bercovici N, Loudovaris M, Guillermo R, Lee SM, Bender J, Mills B, Fong L. PMID: 17893568.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCellsCTClinical Trials
    187. Colon cancer. J Natl Compr Canc Netw. 2007 Oct; 5(9):884-925. Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP. PMID: 17977501.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    188. Rectal cancer. J Natl Compr Canc Netw. 2007 Oct; 5(9):940-81. Engstrom PF, Arnoletti JP, Benson AB, Chen YJ, Choti MA, Cooper HS, Dilawari RA, Early DS, Fakih MG, Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saltz L, Shibata D, Skibber JM, Venook AP. PMID: 17977503.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    189. An alternative therapy for patients with hepatic impairment? Onkologie. 2007 Oct; 30(10):474-5. Choo SP, Venook AP. PMID: 17890884.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    190. Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer. Cancer. 2007 Sep 01; 110(5):980-8. Hecht JR, Patnaik A, Berlin J, Venook A, Malik I, Tchekmedyian S, Navale L, Amado RG, Meropol NJ. PMID: 17671985.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansCTClinical Trials
    191. End points in advanced colon cancer clinical trials: a review and proposal. J Clin Oncol. 2007 Aug 20; 25(24):3572-5. Allegra C, Blanke C, Buyse M, Goldberg R, Grothey A, Meropol NJ, Saltz L, Venook A, Yothers G, Sargent D. PMID: 17704403.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    192. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol. 2007 Oct; 102(10):2196-205. Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, Satomura S, Schwartz ME. PMID: 17617202.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    193. Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer? Surg Oncol Clin N Am. 2007 Jul; 16(3):639-51, x. Nakakura EK, Venook AP, Bergsland EK. PMID: 17606198.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    194. Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma. Clin Colorectal Cancer. 2007 May; 6(7):536-8. Venook AP, Blanke CD, Niedzwiecki D, Lenz HJ, Taylor JR, Hollis DR, Sutherland S, Goldberg RM. PMID: 17553204.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    195. A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys. 2007 Jul 01; 68(3):809-16. Ko AH, Quivey JM, Venook AP, Bergsland EK, Dito E, Schillinger B, Tempero MA. PMID: 17363191.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    196. Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver. Clin Imaging. 2007 Jan-Feb; 31(1):6-10. Qayyum A, Lee GK, Yeh BM, Allen JN, Venook AP, Coakley FV. PMID: 17189839.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    197. Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol. 2006 Oct; 13(10):1284-92. Bartlett DL, Berlin J, Lauwers GY, Messersmith WA, Petrelli NJ, Venook AP. PMID: 16955384.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    198. Hepatobiliary cancers. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2006 Sep; 4(8):728-50. Benson AB, Bekaii-Saab T, Ben-Josef E, Blumgart L, Clary BM, Curley SA, Davila R, Earle CC, Ensminger WD, Gibbs JF, Laheru D, Langnas AN, Mulvihill SJ, Nemcek AA, Posey JA, Sigurdson ER, Sinanan M, Vauthey JN, Venook AP, Wagman LD, Yeatman TJ. PMID: 16948952.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    199. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors. J Clin Oncol. 2006 Aug 01; 24(22):3555-61. Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS. PMID: 16877721.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    200. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective. Clin Cancer Res. 2006 Jun 01; 12(11 Pt 2):3612s-6s. Ratain MJ, Miller AA, McLeod HL, Venook AP, Egorin MJ, Schilsky RL. PMID: 16740794.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    201. Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial. Cancer Gene Ther. 2006 Feb; 13(2):169-81. Atencio IA, Grace M, Bordens R, Fritz M, Horowitz JA, Hutchins B, Indelicato S, Jacobs S, Kolz K, Maneval D, Musco ML, Shinoda J, Venook A, Wen S, Warren R. PMID: 16082381.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    202. Targeted therapy in colorectal cancer. Clin Adv Hematol Oncol. 2006 Feb; 4(2):124-32. Rajpal S, Venook AP. PMID: 16728921.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    203. Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas. J Clin Oncol. 2006 Jan 20; 24(3):379-85. Ko AH, Dito E, Schillinger B, Venook AP, Bergsland EK, Tempero MA. PMID: 16344320.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    204. Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma. Clin Colorectal Cancer. 2005 Nov; 5(4):292-4. Venook AP, Blanke CD, Niedzwiecki D, Lenz HJ, Taylor JR, Hollis DR, Sutherland S, Goldberg RM. PMID: 16356309.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    205. Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Br J Cancer. 2005 Jul 25; 93(2):195-9. Ko AH, Hwang J, Venook AP, Abbruzzese JL, Bergsland EK, Tempero MA. PMID: 15999098.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCTClinical Trials
    206. Rectal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005 Jul; 3(4):492-508. Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ. PMID: 16038640.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    207. Colon cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005 Jul; 3(4):468-91. Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ. PMID: 16038639.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    208. Anal canal cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2005 Jul; 3(4):510-5. Engstrom PF, Benson AB, Chen YJ, Choti MA, Dilawari RA, Enke CA, Fakih MG, Fuchs C, Kiel K, Knol JA, Leong LA, Ludwig KA, Martin EW, Rao S, Saif MW, Saltz L, Skibber JM, Venook AP, Yeatman TJ. PMID: 16038641.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    209. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma. Cancer. 2005 Jun 15; 103(12):2435-46. Venook AP. PMID: 15880563.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    210. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant. 2005 Apr; 5(4 Pt 1):795-804. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R, Kerlan R, Venook A, Ascher NL, Emond JC, Roberts JP. PMID: 15760404.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    211. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist. 2005 Apr; 10(4):250-61. Venook A. PMID: 15821245.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    212. Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer. Clin Cancer Res. 2005 Mar 01; 11(5):1791-7. Mehta KR, Nakao K, Zuraek MB, Ruan DT, Bergsland EK, Venook AP, Moore DH, Tokuyasu TA, Jain AN, Warren RS, Terdiman JP, Waldman FM. PMID: 15756001.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    213. Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials. Semin Oncol. 2004 Dec; 31(6 Suppl 13):53-90. Alberts DS, Muggia FM, Carmichael J, Winer EP, Jahanzeb M, Venook AP, Skubitz KM, Rivera E, Sparano JA, DiBella NJ, Stewart SJ, Kavanagh JJ, Gabizon AA. PMID: 15717738.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    214. Cetuximab in the treatment of colorectal cancer. Clin Adv Hematol Oncol. 2004 Nov; 2(11):1-10; quiz 11-12. Goldberg RM, Venook AP, Schilsky RL. PMID: 16170891.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    215. Regional therapy of liver metastases. Curr Treat Options Oncol. 2004 Oct; 5(5):427-37. Whisenant J, Venook A. PMID: 15341680.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    216. Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition. J Natl Compr Canc Netw. 2004 Sep; 2 Suppl 2:S74-84. Venook AP. PMID: 19780248.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    217. Key research issues in the management of hepatocellular carcinoma. Cancer Chemother Pharmacol. 2004 Sep; 54 Suppl 1:S87-90. Venook AP. PMID: 15309518.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    218. Hepatocellular carcinoma: epidemic and treatment. Curr Oncol Rep. 2004 May; 6(3):177-83. Allen J, Venook A. PMID: 15066228.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    219. Reactivation of hepatitis C virus after chemotherapy for colon cancer. Clin Oncol (R Coll Radiol). 2004 May; 16(3):204-5. Melisko ME, Fox R, Venook A. PMID: 15191008.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    220. Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer. Oncology (Williston Park). 2004 May; 18(6):762-8; discussion 769-73. Whisenant J, Venook A. PMID: 15214595.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    221. Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients. Radiology. 2004 Jan; 230(1):287-93. Wilson MW, Kerlan RK, Fidelman NA, Venook AP, LaBerge JM, Koda J, Gordon RL. PMID: 14695402.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    222. A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863. Ann Oncol. 2003 Dec; 14(12):1783-90. Venook AP, Enders Klein C, Fleming G, Hollis D, Leichman CG, Hohl R, Byrd J, Budman D, Villalona M, Marshall J, Rosner GL, Ramirez J, Kastrissios H, Ratain MJ. PMID: 14630685.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    223. Induction therapy in patients with metastatic colorectal cancer. Semin Oncol. 2003 Aug; 30(4 Suppl 12):25-9. Venook AP. PMID: 14508724.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    224. Colorectal metastases confined to the liver: a unique opportunity? Semin Oncol. 2003 Aug; 30(4 Suppl 15):34-9. Venook AP. PMID: 14523793.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    225. Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal. Surg Oncol. 2003 Jul; 12(1):1-7. Visser BC, Venook AP, Patti MG. PMID: 12689665.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    226. Testing the water before diving off the cutting edge. Ann Surg Oncol. 2003 May; 10(4):332-3. Venook AP. PMID: 12734077.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    227. Shedding old paradigms: developing viruses to treat cancer. J Clin Oncol. 2002 May 01; 20(9):2220-2. Bergsland EK, Venook AP. PMID: 11980991.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    228. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001 Jun; 33(6):1394-403. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. PMID: 11391528.
      View in: PubMed   Mentions: 458     Fields:    Translation:Humans
    229. Therapeutic approaches to metastasis confined to the liver. Curr Oncol Rep. 2001 Mar; 3(2):109-15. Venook AP, Warren RS. PMID: 11177742.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    230. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Ther. 2001 Feb; 8(4):308-15. Mulvihill S, Warren R, Venook A, Adler A, Randlev B, Heise C, Kirn D. PMID: 11313805.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansCellsCTClinical Trials
    231. Hepatocellular carcinoma. Curr Treat Options Oncol. 2000 Dec; 1(5):407-15. Venook AP. PMID: 12057148.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    232. NCCN Practice Guidelines for Colorectal Cancer. Oncology (Williston Park). 2000 Nov; 14(11A):203-12. Benson AB, Choti MA, Cohen AM, Doroshow JH, Fuchs C, Kiel K, Martin EW, McGinn C, Petrelli NJ, Posey JA, Skibber JM, Venook A, Yeatman TJ. PMID: 11195411.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    233. Hepatocellular carcinoma. Curr Opin Oncol. 2000 Jul; 12(4):357-61. Bergsland EK, Venook AP. PMID: 10888422.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    234. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol. 2000 Jul; 18(14):2780-7. Venook AP, Egorin MJ, Rosner GL, Hollis D, Mani S, Hawkins M, Byrd J, Hohl R, Budman D, Meropol NJ, Ratain MJ. PMID: 10894879.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    235. Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer. N Engl J Med. 2000 May 18; 342(20):1524; author reply 1526-7. Venook AP, Althaus B, Warren RS. PMID: 10819648.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    236. Regional strategies for managing hepatocellular carcinoma. Oncology (Williston Park). 2000 Mar; 14(3):347-54; discussion 354, 359, 363-4. Venook AP. PMID: 10742963.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    237. Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation. Ann Surg Oncol. 1999 Jun; 6(4):350-8. Bloom AI, Gordon RL, Ahl KH, Kerlan RK, LaBerge JM, Wilson MW, Venook AP, Warren R. PMID: 10379855.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    238. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clin Oncol. 1999 Feb; 17(2):600-6. Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R, Saltz L, Dandona P, Anthony L. PMID: 10080605.
      View in: PubMed   Mentions: 74     Fields:    Translation:HumansCTClinical Trials
    239. Embolization and chemoembolization therapy for neuroendocrine tumors. Curr Opin Oncol. 1999 Jan; 11(1):38-41. Venook AP. PMID: 9914876.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    240. Tamoxifen in liver disease: potential exacerbation of hepatic dysfunction. Ann Oncol. 1998 Oct; 9(10):1123-6. Floren LC, Hebert MF, Venook AP, Jordan VC, Cisneros A, Somberg KA. PMID: 9834826.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    241. Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264. J Clin Oncol. 1998 May; 16(5):1811-9. Venook AP, Egorin MJ, Rosner GL, Brown TD, Jahan TM, Batist G, Hohl R, Budman D, Ratain MJ, Kearns CM, Schilsky RL. PMID: 9586895.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    242. Update on hepatic intra-arterial chemotherapy. Oncology (Williston Park). 1997 Jul; 11(7):947-57; discussion 961-2, 964, 970. Venook AP. PMID: 9251115.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    243. Can a vitamin prevent hepatocellular carcinoma? Hepatology. 1997 Jan; 25(1):249-50. Venook AP. PMID: 8985300.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    244. Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile. Mod Pathol. 1996 Jun; 9(6):703-9. Dorsey BV, Benjamin LE, Rauscher F, Klencke B, Venook AP, Warren RS, Weidner N. PMID: 8782211.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    245. Practice guidelines for esophageal cancer. Cancer J Sci Am. 1996 May-Jun; 2(3A Suppl):S37-43. Goodnight J, Venook A, Ames M, Taylor C, Gilden R, Figlin RA. PMID: 9166522.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    246. Practice guidelines for pancreatic cancer. Cancer J Sci Am. 1996 May-Jun; 2(3A Suppl):S53-60. Goodnight J, Venook A, Fringer J, Taylor C, Gilden R, Figlin RA. PMID: 9166524.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    247. Practice guidelines for colorectal cancer. Cancer J Sci Am. 1996 May-Jun; 2(3A Suppl):S23-36. Venook A, Goodnight J, Kumar S, Taylor C, Gilden R, Figlin RA. PMID: 9166521.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    248. Practice guidelines for gastric cancer. Cancer J Sci Am. 1996 May-Jun; 2(3A Suppl):S45-52. Venook A, Goodnight J, Smith NG, Taylor C, Gilden R, Figlin RA. PMID: 9166523.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    249. Regional chemotherapy approaches for primary and metastatic liver tumors. Surg Oncol Clin N Am. 1996 Apr; 5(2):411-427. Venook AP, Warren RS. PMID: 9019361.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    250. Pulmonary aspergillosis masquerading as progressive post-transplant lymphoma. Transpl Int. 1996; 9(5):517-9. Kirn D, Venook A, Pena I. PMID: 8875798.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    251. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg. 1995 Jul; 1(4):242-8. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, Ascher NL, Lake JR. PMID: 9346574.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    252. Treatment of hepatocellular carcinoma: too many options? J Clin Oncol. 1994 Jun; 12(6):1323-34. Venook AP. PMID: 8201395.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    253. Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease. Cancer. 1993 Aug 01; 72(3):905-8. Small EJ, Venook AP, Damon LE. PMID: 8334644.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    254. Liver transplantation for hepatocellular carcinoma. Hepatology. 1993 Jul; 18(1):218-9. Venook AP. PMID: 8392028.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    255. A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma. Cancer. 1993 Jun 01; 71(11):3601-4. Wilkinson MJ, Frye JW, Small EJ, Venook AP, Carroll PR, Ernest ML, Stagg RJ. PMID: 8490909.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    256. The Sweet syndrome during therapy with granulocyte colony-stimulating factor. Ann Intern Med. 1992 Jun 15; 116(12 Pt 1):996-8. Park JW, Mehrotra B, Barnett BO, Baron AD, Venook AP. PMID: 1375012.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    257. Hepatic cancers and their response to chemoembolization therapy. Quantitative image-guided 31P magnetic resonance spectroscopy. Invest Radiol. 1992 Jun; 27(6):456-64. Meyerhoff DJ, Karczmar GS, Valone F, Venook A, Matson GB, Weiner MW. PMID: 1318873.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    258. Hepatic intra-arterial methylene blue injection during endoscopy: a method of detecting gastroduodenal misperfusion in patients receiving hepatic intra-arterial chemotherapy via an implanted pump. Gastrointest Endosc. 1992 Jan-Feb; 38(1):52-4. Frye JW, Venook AP, Ostroff JW, Mulvihill SJ, Warren RS, Pellegrini CA, Ring EJ, Stagg RJ. PMID: 1612381.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    259. Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst. 1991 Mar 20; 83(6):423-8. Stagg RJ, Venook AP, Chase JL, Lewis BJ, Warren RS, Roh M, Mulvihill SJ, Grobman BJ, Rayner AA, Hohn DC. PMID: 1825674.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    260. Chemoembolization for hepatocellular carcinoma. J Clin Oncol. 1990 Jun; 8(6):1108-14. Venook AP, Stagg RJ, Lewis BJ, Chase JL, Ring EJ, Maroney TP, Hohn DC. PMID: 2161449.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    261. Activity of coumarin and cimetidine in metastatic renal cell carcinoma. J Clin Oncol. 1989 Mar; 7(3):402-3. Venook AP, Davenport Y, Tseng A. PMID: 2918335.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    262. Elevated plasma tamoxifen levels in a patient with liver obstruction. Cancer Chemother Pharmacol. 1989; 23(3):194-5. DeGregorio MW, Wiebe VJ, Venook AP, Holleran WM. PMID: 2924377.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    263. Regional chemotherapy for colorectal cancer metastatic to the liver. Oncology (Williston Park). 1988 Mar; 2(3):19-26. Venook AP, Stagg RJ, Lewis BJ. PMID: 3079322.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    264. Pentoxifylline and aplastic anemia. Ann Intern Med. 1987 Sep; 107(3):427-8. Mass RD, Venook AP, Linker CA, Zipkin RE. PMID: 3619234.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    265. Prophylactic heparin in APL. Blood. 1987 Sep; 70(3):886-7. Venook AP, Shuman MA, Corash L. PMID: 3476166.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    266. Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group. J Clin Oncol. 1987 Jun; 5(6):951-5. Venook AP, Tseng A, Meyers FJ, Silverberg I, Boles R, Fu KK, Jacobs CD. PMID: 3585449.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    267. Initiation of warfarin therapy: comparison of physician dosing with computer-assisted dosing. J Gen Intern Med. 1987 May-Jun; 2(3):141-8. White RH, Hong R, Venook AP, Daschbach MM, Murray W, Mungall DR, Coleman RW. PMID: 3295148.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    Alan's Networks
    Concepts (618)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (106)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑